AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates Despite strength in the Med Tech business, AngioDynamics (ANGO) registers overall soft performance in third-quarter fiscal 2024.…
AngioDynamics (ANGO) Settles Patent Litigations With BD AngioDynamics (ANGO) announces its settlement agreement with BDs affiliate, C.R. Bard, to resolve a 10-year dispute over outstanding patent litigation.…